Showing results (71-80 of 112) with videos related to
Sort By:
Pageof 12
Journal of Medicinal Chemistry|July 18, 2009
Design, synthesis, and biological evaluation of 16-substituted 4-azasteroids as tissue-selective androgen receptor modulators (SARMs)Helen J Mitchell, William P Dankulich, George D Hartman, et al.Bioorganic & Medicinal Chemistry Letters|March 31, 2007
Kinesin spindle protein (KSP) inhibitors. Part V: discovery of 2-propylamino-2,4-diaryl-2,5-dihydropyrroles as potent, water-soluble KSP inhibitors, and modulation of their basicity by beta-fluorination to overcome cellular efflux by P-glycoproteinChristopher D Cox, Michael J Breslin, David B Whitman, et al.Bioorganic & Medicinal Chemistry Letters|November 13, 2013
Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs)Swati P Mercer, Anthony J Roecker, Susan Garson, et al.Bioorganic & Medicinal Chemistry Letters|April 23, 2010
3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead effortsEdward J Brnardic, Mark E Fraley, Robert M Garbaccio, et al.Bioorganic & Medicinal Chemistry Letters|January 22, 2008
Proline bis-amides as potent dual orexin receptor antagonistsJeffrey M Bergman, Anthony J Roecker, Swati P Mercer, et al.Bioorganic & Medicinal Chemistry Letters|February 3, 2009
Discovery of GlyT1 inhibitors with improved pharmacokinetic propertiesScott E Wolkenberg, Zhijian Zhao, David D Wisnoski, et al.Bioorganic & Medicinal Chemistry Letters|June 1, 2010
Synthesis and evaluation of a new series of Neuropeptide S receptor antagonistsJeffrey Y Melamed, Amy E Zartman, Nathan R Kett, et al.Journal of Medicinal Chemistry|November 28, 2006
Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillationB Wesley Trotter, Kausik K Nanda, Nathan R Kett, et al.Bioorganic & Medicinal Chemistry Letters|December 18, 2007
Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)Zhijian Zhao, Scott E Wolkenberg, Philip E J Sanderson, et al.Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSPAnthony J Roecker, Paul J Coleman, Swati P Mercer, et al.Pageof 12